COL5A1 and lung adenocarcinoma: However, when we knocked down COL5A1 in CAFs or treated them with Sorafenib, the invasive capacity of lung adenocarcinoma cells co-cultured with CAFs decreased compared with scrambled transfected CAFs (Fig. 7k).